Cargando…

Assessment of anxiety/depression among cancer patients before and during the COVID‐19 pandemic

OBJECTIVE: To assess differences in the prevalence of anxiety/depression symptoms among cancer patients before (2019) and during the COVID‐19 pandemic (2020); and the associations between anxiety/depression and sociodemographic and health behavior factors among cancer patients before and during the...

Descripción completa

Detalles Bibliográficos
Autores principales: Adzrago, David, Sulley, Saanie, Tagoe, Ishmael, Ormiston, Cameron K., Odame, Emmanuel A., Mamudu, Lohuwa, Williams, Faustine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9762178/
https://www.ncbi.nlm.nih.gov/pubmed/36029183
http://dx.doi.org/10.1002/pon.6026
_version_ 1784852815881961472
author Adzrago, David
Sulley, Saanie
Tagoe, Ishmael
Ormiston, Cameron K.
Odame, Emmanuel A.
Mamudu, Lohuwa
Williams, Faustine
author_facet Adzrago, David
Sulley, Saanie
Tagoe, Ishmael
Ormiston, Cameron K.
Odame, Emmanuel A.
Mamudu, Lohuwa
Williams, Faustine
author_sort Adzrago, David
collection PubMed
description OBJECTIVE: To assess differences in the prevalence of anxiety/depression symptoms among cancer patients before (2019) and during the COVID‐19 pandemic (2020); and the associations between anxiety/depression and sociodemographic and health behavior factors among cancer patients before and during the pandemic. METHODS: We analyzed data from the 2019 (n = 856) and 2020 (n = 626) Health Information National Trends Survey, a nationally representative survey of United States adults aged ≥18 years. Only adults with a cancer diagnosis were used in the analyses. Anxiety/depression was assessed using the Patient Health Questionnaire‐4 (low/none [0–2], mild [3–5], moderate [6–8], and severe [9–12]) and dichotomized as low/none and current anxiety/depression (mild/moderate/severe). Multivariate analysis was performed. RESULTS: The prevalence of anxiety/depression symptoms among cancer patients was 32.7% before the COVID‐19 pandemic and 31.1% during the pandemic. The odds of anxiety/depression among patients with fair/poor health status was higher during the pandemic relative to before (before: odds ratio [OR] = 1.85 vs. during: OR = 3.89). Participants aged 50–64 years (before: OR = 0.29, 95% confidence interval [95% CI] = 0.11–0.76; during: OR = 0.33, 95% CI = 0.11–0.97) and ≥65 years (before: OR = 0.13, 95% CI = 0.05–0.34; during: OR = 0.18, 95% CI = 0.07–0.47) had lower odds of anxiety/depression before and during the pandemic compared to those aged 35–49 years. Hispanics/Latinos had higher odds of anxiety/depression (OR = 2.70, 95% CI = 1.11–6.57) before the pandemic and lower odds of anxiety/depression during the pandemic (OR = 0.2, 95% CI = 0.05–1.01) compared to non‐Hispanic Whites. Those who completed high school (before: OR = 0.08, 95% CI = 0.01–0.42), some college (before: OR = 0.10, 95% CI = 0.02–0.42), ≥college degree had lower odds of anxiety/depression symptoms (before: OR = 0.05, 95% CI = 0.01–0.26; during: OR = 0.06, 95% CI = 0.01–0.61) compared to those with less than a high school education. CONCLUSION: Our results suggest the need to increase the provision of mental health services to cancer patients at high risk of developing anxiety/depression symptoms, particularly during public health emergencies, to alleviate further health burdens.
format Online
Article
Text
id pubmed-9762178
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-97621782022-12-19 Assessment of anxiety/depression among cancer patients before and during the COVID‐19 pandemic Adzrago, David Sulley, Saanie Tagoe, Ishmael Ormiston, Cameron K. Odame, Emmanuel A. Mamudu, Lohuwa Williams, Faustine Psychooncology Original Articles OBJECTIVE: To assess differences in the prevalence of anxiety/depression symptoms among cancer patients before (2019) and during the COVID‐19 pandemic (2020); and the associations between anxiety/depression and sociodemographic and health behavior factors among cancer patients before and during the pandemic. METHODS: We analyzed data from the 2019 (n = 856) and 2020 (n = 626) Health Information National Trends Survey, a nationally representative survey of United States adults aged ≥18 years. Only adults with a cancer diagnosis were used in the analyses. Anxiety/depression was assessed using the Patient Health Questionnaire‐4 (low/none [0–2], mild [3–5], moderate [6–8], and severe [9–12]) and dichotomized as low/none and current anxiety/depression (mild/moderate/severe). Multivariate analysis was performed. RESULTS: The prevalence of anxiety/depression symptoms among cancer patients was 32.7% before the COVID‐19 pandemic and 31.1% during the pandemic. The odds of anxiety/depression among patients with fair/poor health status was higher during the pandemic relative to before (before: odds ratio [OR] = 1.85 vs. during: OR = 3.89). Participants aged 50–64 years (before: OR = 0.29, 95% confidence interval [95% CI] = 0.11–0.76; during: OR = 0.33, 95% CI = 0.11–0.97) and ≥65 years (before: OR = 0.13, 95% CI = 0.05–0.34; during: OR = 0.18, 95% CI = 0.07–0.47) had lower odds of anxiety/depression before and during the pandemic compared to those aged 35–49 years. Hispanics/Latinos had higher odds of anxiety/depression (OR = 2.70, 95% CI = 1.11–6.57) before the pandemic and lower odds of anxiety/depression during the pandemic (OR = 0.2, 95% CI = 0.05–1.01) compared to non‐Hispanic Whites. Those who completed high school (before: OR = 0.08, 95% CI = 0.01–0.42), some college (before: OR = 0.10, 95% CI = 0.02–0.42), ≥college degree had lower odds of anxiety/depression symptoms (before: OR = 0.05, 95% CI = 0.01–0.26; during: OR = 0.06, 95% CI = 0.01–0.61) compared to those with less than a high school education. CONCLUSION: Our results suggest the need to increase the provision of mental health services to cancer patients at high risk of developing anxiety/depression symptoms, particularly during public health emergencies, to alleviate further health burdens. John Wiley and Sons Inc. 2022-09-14 2022-10 /pmc/articles/PMC9762178/ /pubmed/36029183 http://dx.doi.org/10.1002/pon.6026 Text en © 2022 The Authors. Psycho-Oncology published by John Wiley & Sons Ltd. This article has been contributed to by U.S. Government employees and their work is in the public domain in the USA. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Original Articles
Adzrago, David
Sulley, Saanie
Tagoe, Ishmael
Ormiston, Cameron K.
Odame, Emmanuel A.
Mamudu, Lohuwa
Williams, Faustine
Assessment of anxiety/depression among cancer patients before and during the COVID‐19 pandemic
title Assessment of anxiety/depression among cancer patients before and during the COVID‐19 pandemic
title_full Assessment of anxiety/depression among cancer patients before and during the COVID‐19 pandemic
title_fullStr Assessment of anxiety/depression among cancer patients before and during the COVID‐19 pandemic
title_full_unstemmed Assessment of anxiety/depression among cancer patients before and during the COVID‐19 pandemic
title_short Assessment of anxiety/depression among cancer patients before and during the COVID‐19 pandemic
title_sort assessment of anxiety/depression among cancer patients before and during the covid‐19 pandemic
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9762178/
https://www.ncbi.nlm.nih.gov/pubmed/36029183
http://dx.doi.org/10.1002/pon.6026
work_keys_str_mv AT adzragodavid assessmentofanxietydepressionamongcancerpatientsbeforeandduringthecovid19pandemic
AT sulleysaanie assessmentofanxietydepressionamongcancerpatientsbeforeandduringthecovid19pandemic
AT tagoeishmael assessmentofanxietydepressionamongcancerpatientsbeforeandduringthecovid19pandemic
AT ormistoncameronk assessmentofanxietydepressionamongcancerpatientsbeforeandduringthecovid19pandemic
AT odameemmanuela assessmentofanxietydepressionamongcancerpatientsbeforeandduringthecovid19pandemic
AT mamudulohuwa assessmentofanxietydepressionamongcancerpatientsbeforeandduringthecovid19pandemic
AT williamsfaustine assessmentofanxietydepressionamongcancerpatientsbeforeandduringthecovid19pandemic